Harrow Health, Inc.

Total Valuation

Harrow Health, Inc. carries a market capitalization of 1.44B, placing it among publicly traded companies globally. Its enterprise value stands at 1.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Harrow Health, Inc. currently has 37.48M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 5.73, and the price-to-book ratio stands at 104.73.

Enterprise Valuation

On an enterprise value basis, Harrow Health, Inc. trades at an EV/EBITDA multiple of 94.80 and an EV/FCF ratio of 35.34. The EV/Sales ratio of 6.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 212.78 provides insight into valuation relative to core operating earnings.

Financial Position

Harrow Health, Inc. maintains a current ratio of 2.24, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2,025.89, indicating elevated leverage, while an interest coverage ratio of 0.83 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Harrow Health, Inc. has paid 3.80M in income taxes, reflecting an effective tax rate of 36.27.

Stock Price Statistics

Harrow Health, Inc.'s stock has declined approximately -3.09278% over the past 52 weeks. The 50-day moving average sits at 40.84, while the 200-day moving average is 41.29.

Income Statement

Over the trailing twelve months, Harrow Health, Inc. generated 275.59M in revenue and converted that into -37.23M in net income, yielding earnings per share of -0.98. EBITDA reached 19.08M, while operating income came in at -2.75M.

Balance Sheet

Harrow Health, Inc. holds 83.89M in cash and equivalents against 300.74M in total debt, resulting in a net debt position of 208.49M. Total book value stands at 15.20M, with working capital of 127.14M providing operational flexibility.

Cash Flow

Harrow Health, Inc. produced 6.25M in operating cash flow over the past twelve months. After subtracting -19.33M in capital expenditures, free cash flow totaled -13.08M - equivalent to -0.35 per share.

Margins

Harrow Health, Inc. operates with a gross margin of 73.28, reflecting its pricing power and cost economics. The operating margin of -1.00 and net profit margin of -13.51 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Harrow Health, Inc.'s most recent stock split took place on February 8, 2013 with a 5:1 split ratio.

Scores

Harrow Health, Inc. posts an Altman Z-Score of 2.95, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.